SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy

Diabetic cardiomyopathy (DCM) characterized by diastolic and systolic dysfunction independently of hypertension and coronary heart disease, eventually develops into heart failure, which is strongly linked to a high prevalence of mortality in people with diabetes mellitus (DM). Sodium–glucose cotrans...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Zhou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654518/
https://www.ncbi.nlm.nih.gov/pubmed/33192053
http://dx.doi.org/10.2147/DDDT.S269514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654518/
https://www.ncbi.nlm.nih.gov/pubmed/33192053
http://dx.doi.org/10.2147/DDDT.S269514

Ejemplares similares